Europe – IMAA – Institute for Mergers, Acquisitions, and Alliances

Publications

A Better Way To M&A: Zeroing In On Telecom Value

by McKinsey & Company
With organic growth opportunities narrowing, telecom players need a better way to screen potential M&A targets. A data-rich, heat map–based approach can help. The recent surge in telecom M&A activity raises an important question: which acquisitions will create the most value for your company? Always important, mergers and acquisitions (M&As) have become essential among expansion-minded telecom players in Europe as organic growth opportunities begin to evaporate. […] Read more

November 19, 2016

Deal Tectonics: At The Fault Line Of Growth Goals And Competitive Pressures

Publications

Deal Capsule: Transactions In Chemicals & Pharmaceuticals July 2016

by KPMG
The number of completed deals remained high in both sectors in HY1 2016. While total deal value for pharmaceuticals decreased, chemicals witnessed a 40% increase in HY1 2016 versus HY1 2015. Pharmaceutical M&A was impacted by stock market volatility, while new US regulatory rules struck down the $160 billion Pfizer-Allergan merger. Oncology and dermatology were key areas of interest for big pharma, who were especially keen on acquiring biotech assets. […] Read more

August 5, 2016

Publications

Deal Capsule: Transactions In Chemicals & Pharmaceuticals April 2016

by KPMG
While the number of completed pharma deals were slightly higher in Q1 2016 versus Q1 2015, deal value was far lower in the absence of any >$10 billion completions. Only one deal exceeded $5 billion in Q1 2016 (versus 8 in Q1 2015). Specialization continues to be a driving force in Q1 2016, especially in sectors such as OTC, rare diseases and oncology. Declines in transaction values were also witnessed in chemicals. Downstream specialty chemicals was the leading focus area, notably in applications, resins and agrochemicals. […] Read more

April 20, 2016

News

Pfizer, Allergan deal dead, what could be next?

by CNBC
A $160 billion merger between Pfizer and Allergan lay in tatters Wednesday and left experts contemplating whether more deals could be hit by new tax rules issued by the U.S. Treasury. The deal, which would have allowed New York-based Pfizer to cut its tax bill by redomiciling to Ireland, has now been formally ended. Fresh rules issued Monday make it tougher for target companies to pass on their overseas registered address and in turn, beneficial tax rates. […] Read more

April 6, 2016

News

Metro will sich aufspalten

by Handelsblatt
Kurz nach seinem Amtsantritt als Metro-Chef im Januar 2012 setzte Olaf Koch ein Zeichen. Er verlegte sein Büro vom Hauptgebäude der Düsseldorfer Zentrale, der Brücke 1, zur Brücke 13, von wo das Tagesgeschäft der Großhandelsmärkte geführt wird. Damit rückte er „Cash & Carry“ wieder in den Fokus des Handelskonzerns – die Sparte, mit der bei Metro vor gut 50 Jahren alles begann. […] Read more

March 31, 2016

Publications

The Power Of Alliances: Partnering For Growth In The Insurance Sector

by KPMG
This is an era of unprecedented change for the insurance sector. New technologies, new customer expectations, new regulations and new competitive pressures are rapidly disrupting the traditional insurance business model. In this environment, insurance organizations have no choice but to adapt. The good news is that the vast majority of insurance executives intuitively know they need to be more innovative. […] Read more

March 24, 2016

Publications

Global Oil And Gas Transactions Review 2015

by Ernst & Young
The dramatic drop in both crude oil and natural gas prices across the year combined with a high level of uncertainty about their future trajectory challenged oil and gas merger and acquisition (M&A) activity in 2015. Crude oil prices, which began the year at US$55 per barrel (Brent), declined to US$37 per barrel by December, the lowest level since May 2004 with natural gas prices experiencing a similar journey. […] Read more

January 27, 2016

Publications

Consumer Currents – Food For Thought: Do Grocers Need To Reinvent Their Business Model?

by KPMG
As Albert Einstein shrewdly remarked: “If you always do what you always did, you will always get what you always got.” In the consumer marketplace in the 21st century we live in an age where innovation and reinvention is the key to growth. That is the challenge – and opportunity. […] Read more

December 17, 2015

Publications

Comparative Analysis Of Mergers And Acquisitions In The New Member States Of European Union

by Elsevier Ltd.
Mergers and acquisitions in the new member states of European Union (EU-10) are investigated in the study. The author concentrates on mergers and acquisitions value creation issue in the region. Event study methodology is employed to investigate the scientific problem of value generation as a consequence of analysed transactions. […] Read more

October 19, 2015

Tag: Europe

A Better Way To M&A: Zeroing In On Telecom Value

Deal Capsule: Transactions In Chemicals & Pharmaceuticals July 2016

Deal Capsule: Transactions In Chemicals & Pharmaceuticals April 2016

Pfizer, Allergan deal dead, what could be next?

Metro will sich aufspalten

The Power Of Alliances: Partnering For Growth In The Insurance Sector

Global Oil And Gas Transactions Review 2015

Consumer Currents – Food For Thought: Do Grocers Need To Reinvent Their Business Model?

Comparative Analysis Of Mergers And Acquisitions In The New Member States Of European Union

Are you sure you
want to log out?

Tag: Europe

Are you sure youwant to log out?

Are you sure you
want to log out?